Kerry Wentworth, VP, Clinical, Reg & Qual at Agenus, holds 50.00K shares in Nuvation Bio (Ticker: NUVB), holds 0.00 shares in Flexion Therapeutics (Ticker: ~FLXN), holds 57.41K shares in Agenus (Ticker: AGEN). Most recently, Kerry Wentworth Bought ― shares of Nuvation Bio on Jun 18, 2025 for an estimated value of 89.74K.
What is the percentage of profitable transactions made by Kerry Wentworth?
The percentage of profitable transactions made by Kerry Wentworth is ―.
What is the average return per transaction made by Kerry Wentworth?
The average return per transaction made by Kerry Wentworth is ―.
What stocks does Kerry Wentworth hold?
Kerry Wentworth holds: AGEN, ~FLXN, NUVB stocks.
What was Kerry Wentworth’s latest transaction?
Kerry Wentworth latest transaction was an Informative Buy of $89.74K.
What was Kerry Wentworth's most profitable transaction?
Kerry Wentworth’s most profitable transaction was an Informative Buy of NUVB stock on June 18, 2025. The return on the trade was 28.40%.
What is Kerry Wentworth's role in Agenus?
Kerry Wentworth's role in Agenus is VP, Clinical, Reg & Qual.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.